Market research
INSP Inspire Medical Systems Inc
NYSE USD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 2B
- P/E ratio
- 13.77
- Analyst target
- 60.4
- Dividend yield
- Not available
- Beta
- 0.67
Profile
Company facts
- Exchange
- NYSE
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- US4577301090
- Market cap
- 2B
- P/E ratio
- 13.77
- Analyst target
- 60.4
- Dividend yield
- Not available
- Beta
- 0.67
About
About Inspire Medical Systems Inc
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the INSP discussion.
5 years, 4 months ago
Inspire Medical Systems, Inc is currently in a long term downtrend where the price is trading 2.5% below its 200 day moving average.
From a valuation standpoint, the stock is 96.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 46.3.
Inspire Medical Systems, Inc's total revenue rose by 71.0% to $46M since the same quarter in the previous year.
Its net income has increased by 17.6% to $-7M since the same quarter in the previous year.
Finally, its free cash flow grew by 27.7% to $-5M since the same quarter in the previous year.
Based on the above factors, Inspire Medical Systems, Inc gets an overall score of 4/5.